Trace amine-associated receptor 1: A promising target for the treatment of psychostimulant addiction

European Journal of Pharmacology

Volumn 761, Issue , 2015, Pages 345-352

  Jing, Li ^a,b   Li, Jun Xu ^a  

^a UNIVERSITY AT BUFFALO   (United States)

^b Department of Physiology and Pathphysiology Tianjin Me dical University   (China)

Author keywords

Addiction; Behavior; Cocaine; Methamphetamine; TAAR 1

Indexed keywords

AMINE; AMPHETAMINE; COCAINE; DRUGS USED IN THE TREATMENT OF ADDICTION; MESSENGER RNA; METHAMPHETAMINE; RO 5166017; RO 5203648; RO 5256390; RO 5263397; TRACE AMINE ASSOCIATES RECEPTOR 1; TRACE AMINE ASSOCIATES RECEPTOR 1 AGONIST; UNCLASSIFIED DRUG; CENTRAL STIMULANT AGENT; G PROTEIN COUPLED RECEPTOR; LIGAND; TRACE AMINE-ASSOCIATED RECEPTOR 1;

AMYGDALOID NUCLEUS; ARTICLE; BRAIN REGION; COCAINE DEPENDENCE; DOPAMINERGIC ACTIVITY; DOPAMINERGIC NERVE CELL; DOPAMINERGIC SYSTEM; DORSAL RAPHE NUCLEUS; DRUG MECHANISM; DRUG RECEPTOR BINDING; LOCUS CERULEUS; METHAMPHETAMINE DEPENDENCE; NERVE CELL PLASTICITY; NEUROTRANSMISSION; NONHUMAN; PHARMACOLOGICAL BLOCKING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PSYCHOSTIMULANT ADDICTION; RAPHE NUCLEUS; REINFORCEMENT; SEROTONINERGIC NERVE CELL; SUBSTANTIA NIGRA; VENTRAL TEGMENTUM; ADDICTION; AGONISTS; AMPHETAMINE-RELATED DISORDERS; ANIMAL; BRAIN; COCAINE-RELATED DISORDERS; DRUG EFFECTS; HUMAN; METABOLISM; PSYCHOLOGY; SIGNAL TRANSDUCTION;

AMPHETAMINE-RELATED DISORDERS; ANIMALS; BEHAVIOR, ADDICTIVE; BRAIN; CENTRAL NERVOUS SYSTEM STIMULANTS; COCAINE-RELATED DISORDERS; DOPAMINERGIC NEURONS; HUMANS; LIGANDS; METHAMPHETAMINE; RECEPTORS, G-PROTEIN-COUPLED; SIGNAL TRANSDUCTION;

EID: 84934782807     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2015.06.019     Document Type: Review

References (62)

1. C. Achat-Mendes, L.J. Lynch, K.A. Sullivan, E.J. Vallender, and G.M. Miller Augmentation of methamphetamine-induced behaviors in transgenic mice lacking the trace amine-associated receptor 1 Pharmacol. Biochem. Behav. 101 2012 201 207
2. A. Badiani, D. Belin, D. Epstein, D. Calu, and Y. Shaham Opiate versus psychostimulant addiction: the differences do matter Nat. Rev. Neurosci. 12 2011 685 700
3. M.D. Berry Mammalian central nervous system trace amines. Pharmacologic amphetamines, physiologic neuromodulators J. Neurochem. 90 2004 257 271
4. M.D. Berry The potential of trace amines and their receptors for treating neurological and psychiatric diseases Rev. Recent Clin. Trials 2 2007 3 19
5. B. Borowsky, N. Adham, K.A. Jones, R. Raddatz, R. Artymyshyn, K.L. Ogozalek, M.M. Durkin, P.P. Lakhlani, J.A. Bonini, S. Pathirana, N. Boyle, X. Pu, E. Kouranova, H. Lichtblau, F.Y. Ochoa, T.A. Branchek, and C. Gerald Trace amines: identification of a family of mammalian G protein-coupled receptors Proc. Natl. Acad. Sci. USA 98 2001 8966 8971
6. A.A. Boulton Trace amines and mental disorders. The canadian journal of neurological sciences Can. J. Neurol. Sci. 7 1980 261 263
7. A. Bradaia, G. Trube, H. Stalder, R.D. Norcross, L. Ozmen, J.G. Wettstein, A. Pinard, D. Buchy, M. Gassmann, M.C. Hoener, and B. Bettler The selective antagonist EPPTB reveals TAAR1-mediated regulatory mechanisms in dopaminergic neurons of the mesolimbic system Proc. Natl. Acad. Sci. USA 106 2009 20081 20086
8. J.R. Bunzow, M.S. Sonders, S. Arttamangkul, L.M. Harrison, G. Zhang, D.I. Quigley, T. Darland, K.L. Suchland, S. Pasumamula, J.L. Kennedy, S.B. Olson, R.E. Magenis, S.G. Amara, and D.K. Grandy Amphetamine, 3,4-methylenedioxymethamphetamine, lysergic acid diethylamide, and metabolites of the catecholamine neurotransmitters are agonists of a rat trace amine receptor Mol. Pharmacol. 60 2001 1181 1188
9. S.A. Burchett, and T.P. Hicks The mysterious trace amines: protean neuromodulators of synaptic transmission in mammalian brain Prog. Neurobiol. 79 2006 223 246
10. R.J. Carey, G. DePalma, E. Damianopoulos, A. Shanahan, C.P. Muller, and J.P. Huston Evidence that the 5-HT1A autoreceptor is an important pharmacological target for the modulation of cocaine behavioral stimulant effects Brain Res. 1034 2005 162 171
11. I.E. Cisneros, and A. Ghorpade Methamphetamine and HIV-1-induced neurotoxicity: role of trace amine associated receptor 1 cAMP signaling in astrocytes Neuropharmacology 85 2014 499 507
12. R. Cotter, Y. Pei, L. Mus, A. Harmeier, R.R. Gainetdinov, M.C. Hoener, and J.J. Canales The trace amine-associated receptor 1 modulates methamphetamine's neurochemical and behavioral effects Front. Neurosci. 9 2015 39
13. T.J. De Vries, A.N. Schoffelmeer, R. Binnekade, A.H. Mulder, and L.J. Vanderschuren Drug-induced reinstatement of heroin- and cocaine-seeking behaviour following long-term extinction is associated with expression of behavioural sensitization Eur. J. Neurosci. 10 1998 3565 3571
14. R.I. Desai, T.A. Kopajtic, M. Koffarnus, A.H. Newman, and J.L. Katz Identification of a dopamine transporter ligand that blocks the stimulant effects of cocaine J. Neurosci. 25 2005 1889 1893
15. 2 receptor Mol. Pharmacol. 80 2011 416 425
16. G. Galley, H. Stalder, A. Goergler, M.C. Hoener, and R.D. Norcross Optimisation of imidazole compounds as selective TAAR1 agonists: discovery of RO5073012 Bioorg. Med. Chem. Lett. 22 2012 5244 5248
17. U.E. Ghitza Needed relapse-prevention research on novel framework (aspire model) for substance use disorders treatment Front. Psychiatry 6 2015 37
18. S. Glasner-Edwards, L.J. Mooney, P. Marinelli-Casey, M. Hillhouse, A. Ang, and R. Rawson Bulimia nervosa among methamphetamine dependent adults: association with outcomes three years after treatment Eat. Disord. 19 2011 259 269
19. R.Z. Goldstein, D. Tomasi, N. Alia-Klein, J. Honorio Carrillo, T. Maloney, P.A. Woicik, R. Wang, F. Telang, and N.D. Volkow Dopaminergic response to drug words in cocaine addiction J. Neurosci. 29 2009 6001 6006
20. D.K. Grandy Trace amine-associated receptor 1-Family archetype or iconoclast? Pharmacol. Ther. 116 2007 355 390
21. A.J. Greenshaw beta-Phenylethylamine and reinforcement Prog. Neuropsychopharmacol. Biol. Psychiatry 8 1984 615 620
22. D.J. Haleem Extending therapeutic use of psychostimulants: focus on serotonin-1A receptor Prog. Neuropsychopharmacol. Biol. Psychiatry 46 2013 170 180
23. J.H. Harkness, X. Shi, A. Janowsky, and T.J. Phillips Trace amine-associated receptor 1 regulation of methamphetamine intake and related traits Neuropsychopharmacology 2015 (Epub ahead of print)
24. D. Hawks, M. Mitcheson, A. Ogborne, and G. Edwards Abuse of methylamphetamine Br. Med. J. 2 1969 715 721
25. S.R. Hursh, C.M. Galuska, G. Winger, and J.H. Woods The economics of drug abuse: a quantitative assessment of drug demand Mol. Interv. 5 2005 20 28
26. L. Jing, Y. Zhang, and J.X. Li Effects of the trace amine associated receptor 1 agonist RO5263397 on abuse-related behavioral indices of methamphetamine in rats Int. J. Neuropsychopharmacol. 18 2014 1 7
27. I.P. Lapin Anxiogenic effect of phenylethylamine and amphetamine in the elevated plus-maze in mice and its attenuation by ethanol Pharmacol. Biochem. Behav. 44 1993 241 243
28. 2-autoreceptor-mediated responses on midbrain dopaminergic cells Br. J. Pharmacol. 160 2010 1509 1520
29. 2 dopamine autoreceptors Neuropharmacology 81 2014 283 291
30. S.D. Liberles, and L.B. Buck A second class of chemosensory receptors in the olfactory epithelium Nature 442 2006 645 650
31. L. Lindemann, M. Ebeling, N.A. Kratochwil, J.R. Bunzow, D.K. Grandy, and M.C. Hoener Trace amine-associated receptors form structurally and functionally distinct subfamilies of novel G protein-coupled receptors Genomics 85 2005 372 385
32. L. Lindemann, C.A. Meyer, K. Jeanneau, A. Bradaia, L. Ozmen, H. Bluethmann, B. Bettler, J.G. Wettstein, E. Borroni, J.L. Moreau, and M.C. Hoener Trace amine-associated receptor 1 modulates dopaminergic activity J. Pharmacol. Exp. Ther. 324 2008 948 956
33. G.A. Marlatt Cue exposure and relapse prevention in the treatment of addictive behaviors Addict. Behav. 15 1990 395 399
34. G.M. Miller The emerging role of trace amine-associated receptor 1 in the functional regulation of monoamine transporters and dopaminergic activity J. Neurochem. 116 2011 164 176
35. C.P. Muller, R.J. Carey, J.P. Huston, and M.A. De Souza Silva Serotonin and psychostimulant addiction: focus on 5-HT1A-receptors Prog. Neurobiol. 81 2007 133 178
36. T.C. Napier, A.A. Herrold, and H. de Wit Using conditioned place preference to identify relapse prevention medications Neurosci. Biobehav. Rev. 37 2013 2081 2086
37. D. Narang, S. Tomlinson, A. Holt, D.D. Mousseau, and G.B. Baker Trace amines and their relevance to psychiatry and neurology: a brief overview Bull. Clin. Psychopharmacol. 21 2011 73 79
38. E.J. Nestler Common molecular and cellular substrates of addiction and memory Neurobiol. Learn. Mem. 78 2002 637 647
39. Y. Pei, J. Lee, D. Leo, R.R. Gainetdinov, M.C. Hoener, and J.J. Canales Activation of the trace amine-associated receptor 1 prevents relapse to cocaine seeking Neuropsychopharmacology 39 2014 2299 2308
40. S.R. Philips, B. Rozdilsky, and A.A. Boulton Evidence for the presence of m-tyramine, p-tyramine, tryptamine, and phenylethylamine in the rat brain and several areas of the human brain Biol. Psychiatry 13 1978 51 57
41. G.C. Quintero Role of nucleus accumbens glutamatergic plasticity in drug addiction Neuropsychiatr. Dis. Treat. 9 2013 1499 1512
42. L. Rajendran, H.J. Knolker, and K. Simons Subcellular targeting strategies for drug design and delivery Nat. Rev. Drug Discov. 9 2010 29 42
43. F.G. Revel, C.A. Meyer, A. Bradaia, K. Jeanneau, E. Calcagno, C.B. Andre, M. Haenggi, M.T. Miss, G. Galley, R.D. Norcross, R.W. Invernizzi, J.G. Wettstein, J.L. Moreau, and M.C. Hoener Brain-specific overexpression of trace amine-associated receptor 1 alters monoaminergic neurotransmission and decreases sensitivity to amphetamine Neuropsychopharmacology 37 2012 2580 2592
44. F.G. Revel, J.L. Moreau, R.R. Gainetdinov, A. Bradaia, T.D. Sotnikova, R. Mory, S. Durkin, K.G. Zbinden, R. Norcross, C.A. Meyer, V. Metzler, S. Chaboz, L. Ozmen, G. Trube, B. Pouzet, B. Bettler, M.G. Caron, J.G. Wettstein, and M.C. Hoener TAAR1 activation modulates monoaminergic neurotransmission, preventing hyperdopaminergic and hypoglutamatergic activity Proc. Natl. Acad. Sci. USA 108 2011 8485 8490
45. F.G. Revel, J.L. Moreau, R.R. Gainetdinov, A. Ferragud, C. Velazquez-Sanchez, T.D. Sotnikova, S.R. Morairty, A. Harmeier, K. Groebke Zbinden, R.D. Norcross, A. Bradaia, T.S. Kilduff, B. Biemans, B. Pouzet, M.G. Caron, J.J. Canales, T.L. Wallace, J.G. Wettstein, and M.C. Hoener Trace amine-associated receptor 1 partial agonism reveals novel paradigm for neuropsychiatric therapeutics Biol. Psychiatry 72 2012 934 942
46. F.G. Revel, J.L. Moreau, B. Pouzet, R. Mory, A. Bradaia, D. Buchy, V. Metzler, S. Chaboz, K.G. Zbinden, G. Galley, R.D. Norcross, D. Tuerck, A. Bruns, S.R. Morairty, T.S. Kilduff, T.L. Wallace, C. Risterucci, J.G. Wettstein, and M.C. Hoener A new perspective for schizophrenia: TAAR1 agonists reveal antipsychotic- and antidepressant-like activity, improve cognition and control body weight Mol. Psychiatry 18 2013 543 556
47. T.E. Robinson, and K.C. Berridge Incentive-sensitization and addiction Addiction 96 2001 103 114
48. A. Salahpour, A.J. Ramsey, I.O. Medvedev, B. Kile, T.D. Sotnikova, E. Holmstrand, V. Ghisi, P.J. Nicholls, L. Wong, K. Murphy, S.R. Sesack, R.M. Wightman, R.R. Gainetdinov, and M.G. Caron Increased amphetamine-induced hyperactivity and reward in mice overexpressing the dopamine transporter Proc. Natl. Acad. Sci. USA 105 2008 4405 4410
49. Y. Shaham, U. Shalev, L. Lu, H. De Wit, and J. Stewart The reinstatement model of drug relapse: history, methodology and major findings Psychopharmacology 168 2003 3 20
50. H.E. Shannon, and W.A. Thompson Behavior maintained under fixed-interval and 2nd-order schedules by intravenous injections of endogenous noncatecholic phenylethylamines in dogs J. Pharmacol. Exp. Ther. 228 1984 691 695
51. I. Sukhanov, S. Espinoza, D.S. Yakovlev, M.C. Hoener, T.D. Sotnikova, and R.R. Gainetdinov TAAR1-dependent effects of apomorphine in mice Int. J. Neuropsychopharmacol. 17 2014 1683 1693
52. D.A. Thorn, L. Jing, Y. Qiu, A.M. Gancarz-Kausch, C.M. Galuska, D.M. Dietz, Y. Zhang, and J.X. Li Effects of the trace amine-associated receptor 1 agonist RO5263397 on abuse-related effects of cocaine in rats Neuropsychopharmacology 39 2014 2309 2316
53. D.A. Thorn, C. Zhang, Y. Zhang, and J.X. Li The trace amine associated receptor 1 agonist RO5263397 attenuates the induction of cocaine behavioral sensitization in rats Neurosci. Lett. 566 2014 67 71
54. M.M. Torregrossa, P.R. Corlett, and J.R. Taylor Aberrant learning and memory in addiction Neurobiol. Learn. Mem. 96 2011 609 623
55. T.M. Tzschentke Measuring reward with the conditioned place preference (CPP) paradigm: update of the last decade Addict. Biol. 12 2007 227 462
56. P. Vezina Sensitization, drug addiction and psychopathology in animals and humans Prog. Neuropsychopharmacol. Biol. Psychiatry 31 2007 1553 1555
57. C.A. Winstanley, D.E.H. Theobald, J.W. Dalley, and T.W. Robbins Interactions between serotonin and dopamine in the control of impulsive choice in rats: therapeutic implications for impulse control disorders Neuropsychopharmacology 30 2005 669 682
58. T.D. Wolinsky, C.J. Swanson, K.E. Smith, H. Zhong, B. Borowsky, P. Seeman, T. Branchek, and C.P. Gerald The Trace Amine 1 receptor knockout mouse: an animal model with relevance to schizophrenia Genes Brain Behav. 6 2007 628 639
59. Z. Xie, and G.M. Miller Trace amine-associated receptor 1 is a modulator of the dopamine transporter J. Pharmacol. Exp. Ther. 321 2007 128 136
60. 2 autoreceptor in vitro J. Pharmacol. Exp. Ther. 321 2007 116 127
61. Z. Xie, and G.M. Miller Beta-phenylethylamine alters monoamine transporter function via trace amine-associated receptor 1: implication for modulatory roles of trace amines in brain J. Pharmacol. Exp. Ther. 325 2008 617 628
62. Z. Xie, and G.M. Miller A receptor mechanism for methamphetamine action in dopamine transporter regulation in brain J. Pharmacol. Exp. Ther. 330 2009 316 325